Suchergebnisse - "rucaparib"

PubPharm (404)

81

The growing role of rucaparib in contemporary treatment of metastatic prostate cancer : a review of efficacy and guidance for side effect management

enthalten in: Expert review of anticancer therapy | 2022

von Rao, A. | Antonarakis, E.

82

Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations

enthalten in: The Lancet. Oncology | 2022

von Ganguly, S. | Gogia, A.

CommentOn: Lancet Oncol. 2022 Apr;23(4):465-478. - PMID 35298906

83

Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations - Authors' reply

enthalten in: The Lancet. Oncology | 2022

von Kristeleit, R. | Oza, A.

CommentOn: Lancet Oncol. 2022 Apr;23(4):465-478. - PMID 35298906

84

PARP inhibitors as single agents and in combination therapy : the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers

enthalten in: Expert opinion on investigational drugs | 2022

von Luo, L. | Keyomarsi, K.

85

Appropriate Selection of PARP Inhibitors in Ovarian Cancer

enthalten in: Current treatment options in oncology | 2022

von Smith, M. | Pothuri, B.

86

Attenuation of Muscle Damage, Structural Abnormalities, and Physical Activity in Respiratory and Limb Muscles following Treatment with Rucaparib in Lung Cancer Cachexia Mice

enthalten in: Cancers | 2022

von Pérez-Peiró, M. | Duran, X. | Yélamos, J. | +1

87

A Case Study of Clinical Response to Rucaparib in a Patient with Metastatic Castration-Resistant Prostate Cancer and a RAD51B Alteration

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Sautois, B. | Loehr, A. | Watkins, S. | +2

88

Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells

enthalten in: Medical sciences (Basel, Switzerland) | 2022

von El Naggar, O. | Doyle, B. | Mariner, K. | +1

89

Imaging PARP with [18F]rucaparib in pancreatic cancer models

enthalten in: European journal of nuclear medicine & molecular imaging | 2022

von Chan, C. | Chen, Z. | Destro, G. | +9

90

Imaging PARP with [18F]rucaparib in pancreatic cancer models

enthalten in: European journal of nuclear medicine and molecular imaging | 2022

von Chan, C. | Chen, Z. | Destro, G. | +9